Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely
Public ClinicalTrials.gov record NCT02545127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Multicenter Trial Exploring the Efficacy and Safety of Intra-nasal Administration of Merotocin in Increasing Milk Production in Maternal Subjects With Preterm Delivery and Inadequate Milk Production
Study identification
- NCT ID
- NCT02545127
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Ferring Pharmaceuticals
- Industry
- Enrollment
- 4 participants
Conditions and interventions
Conditions
Interventions
- Merotocin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 44 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 27, 2021
- Primary completion
- Nov 10, 2022
- Completion
- Nov 10, 2022
- Last update posted
- Feb 6, 2024
2021 – 2022
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ferring Investigational Site | New Haven | Connecticut | 06520 | — |
| Ferring Investigational Site | South Bend | Indiana | 46601 | — |
| Ferring Investigational Site | Baltimore | Maryland | 21201 | — |
| Ferring Investigational Site | Boston | Massachusetts | 02115 | — |
| Ferring Investigational Site | Valhalla | New York | 10595 | — |
| Ferring Investigational Site | Raleigh | North Carolina | 27610 | — |
| Ferring Investigational Site | Cincinnati | Ohio | 45229 | — |
| Ferring Investigational Site | Charleston | South Carolina | 29425 | — |
| Ferring Investigational Site | Houston | Texas | 77030 | — |
| Ferring Investigational Site | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02545127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02545127 live on ClinicalTrials.gov.